Sagimet Biosciences (SGMT) Change in Cash (2022 - 2024)
Sagimet Biosciences (SGMT) posted quarterly Change in Cash of -$80.8 million for Q2 2024, down 1409.85% year-over-year from $6.2 million in Q3 2023, and down 179.52% quarter-over-quarter from $101.6 million in Q1 2024.
Sagimet Biosciences (SGMT) Change in Cash (2022 - 2024) Analysis & Trends
Sagimet Biosciences' Change in Cash history runs 3 years deep, the most recent figure standing at -$80.8 million for Q2 2024.
- In Q2 2024, Change in Cash fell 1409.85% year-over-year to -$80.8 million; the TTM figure through Jun 2024 stood at $4.3 million (down 97.48% YoY), while the FY2025 annual figure was $1.6 million, up 114.43% from the prior year.
- Change in Cash for Q2 2024 stood at -$80.8 million, down from $101.6 million in the prior quarter.
- The five-year high for Change in Cash was $156.2 million in Q4 2022, with the low at -$99.8 million in Q4 2023.
- The 3-year median for Change in Cash is $9.2 million (2023), against an average of $22.1 million.
- The sharpest annual moves came in 2023 and 2024: Change in Cash jumped 3830.26% in 2023, then slumped 1409.85% in 2024.
- Sagimet Biosciences' Change in Cash stood at $156.2 million in 2022, then plunged by 163.9% to -$99.8 million in 2023, then advanced by 19.03% to -$80.8 million in 2024.
- Business Quant data shows SGMT's Change in Cash at -$80.8 million in Q2 2024, $101.6 million in Q1 2024, and -$99.8 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -80.82 Mn |
| Mar 31, 2024 | 101.64 Mn |
| Dec 31, 2023 | -99.81 Mn |
| Sep 30, 2023 | 83.33 Mn |
| Jun 30, 2023 | 6.17 Mn |
| Mar 31, 2023 | 12.18 Mn |
| Dec 31, 2022 | 156.19 Mn |
| Sep 30, 2022 | -2.23 Mn |